Danaher Corporation (DHR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Danaher Corporation (DHR) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.66 Billion) by net assets ($51.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DHR net asset quality index to measure how much of total assets are equity-financed.
Danaher Corporation - Cash Flow Conversion Efficiency Trend (1990–2024)
This chart illustrates how Danaher Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Danaher Corporation cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Danaher Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Danaher Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Allianz SE VNA O.N.
XETRA:ALV
|
0.316x |
|
ConocoPhillips
NYSE:COP
|
0.067x |
|
ALLIANZ SE UNSP.ADR 1/10
F:ALVE
|
N/A |
|
Pfizer Inc
NYSE:PFE
|
0.029x |
|
Airbus SE
F:AIRA
|
-0.072x |
|
Airbus Group SE
PA:AIR
|
-0.063x |
|
Booking Holdings Inc
NASDAQ:BKNG
|
-0.369x |
|
Eaton Corporation PLC
NYSE:ETN
|
0.072x |
Annual Cash Flow Conversion Efficiency for Danaher Corporation (1990–2024)
The table below shows the annual cash flow conversion efficiency of Danaher Corporation from 1990 to 2024. For the full company profile with market capitalisation and key ratios, see Danaher Corporation (DHR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $49.55 Billion | $6.69 Billion | 0.135x | +0.78% |
| 2023-12-31 | $53.49 Billion | $7.16 Billion | 0.134x | -21.25% |
| 2022-12-31 | $50.09 Billion | $8.52 Billion | 0.170x | -8.07% |
| 2021-12-31 | $45.18 Billion | $8.36 Billion | 0.185x | +18.54% |
| 2020-12-31 | $39.78 Billion | $6.21 Billion | 0.156x | +19.60% |
| 2019-12-31 | $30.28 Billion | $3.95 Billion | 0.130x | -8.42% |
| 2018-12-31 | $28.23 Billion | $4.02 Billion | 0.142x | +8.03% |
| 2017-12-31 | $26.37 Billion | $3.48 Billion | 0.132x | -13.57% |
| 2016-12-31 | $23.08 Billion | $3.52 Billion | 0.153x | -4.61% |
| 2015-12-31 | $23.76 Billion | $3.80 Billion | 0.160x | -0.18% |
| 2014-12-31 | $23.45 Billion | $3.76 Billion | 0.160x | +0.36% |
| 2013-12-31 | $22.45 Billion | $3.59 Billion | 0.160x | -10.76% |
| 2012-12-31 | $19.08 Billion | $3.42 Billion | 0.179x | +15.64% |
| 2011-12-31 | $16.97 Billion | $2.63 Billion | 0.155x | +2.25% |
| 2010-12-31 | $13.77 Billion | $2.08 Billion | 0.151x | -2.26% |
| 2009-12-31 | $11.63 Billion | $1.80 Billion | 0.155x | -18.30% |
| 2008-12-31 | $9.81 Billion | $1.86 Billion | 0.190x | +4.63% |
| 2007-12-31 | $9.09 Billion | $1.65 Billion | 0.181x | -22.21% |
| 2006-12-31 | $6.64 Billion | $1.55 Billion | 0.233x | -1.73% |
| 2005-12-31 | $5.08 Billion | $1.20 Billion | 0.237x | +5.95% |
| 2004-12-31 | $4.62 Billion | $1.03 Billion | 0.224x | -5.33% |
| 2003-12-31 | $3.65 Billion | $861.54 Million | 0.236x | +0.10% |
| 2002-12-31 | $3.01 Billion | $710.35 Million | 0.236x | -13.55% |
| 2001-12-31 | $2.23 Billion | $608.47 Million | 0.273x | +3.53% |
| 2000-12-31 | $1.94 Billion | $512.25 Million | 0.264x | +7.53% |
| 1999-12-31 | $1.71 Billion | $419.10 Million | 0.245x | +0.07% |
| 1998-12-31 | $1.35 Billion | $331.30 Million | 0.245x | -19.28% |
| 1997-12-31 | $916.90 Million | $278.40 Million | 0.304x | +11.93% |
| 1996-12-31 | $800.30 Million | $217.10 Million | 0.271x | -8.70% |
| 1995-12-31 | $586.30 Million | $174.20 Million | 0.297x | -2.04% |
| 1994-12-31 | $476.10 Million | $144.40 Million | 0.303x | -18.77% |
| 1993-12-31 | $363.70 Million | $135.80 Million | 0.373x | +78.45% |
| 1992-12-31 | $348.40 Million | $72.90 Million | 0.209x | +59.84% |
| 1991-12-31 | $319.30 Million | $41.80 Million | 0.131x | -42.96% |
| 1990-12-31 | $305.00 Million | $70.00 Million | 0.230x | -- |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more